PLAUR and breast cancer: Yang et al. engineered uPAR-targeted magnetic iron oxide nanoparticle (IONP)-encapsulated Dox conjugated with the ATF of uPA that delivered higher Dox loads and exerted a stronger inhibitory effect on breast cancer cell growth than nontargeted NPs.